Lancet endorses Sputnik Light for safety and immune response

Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules

Transforming Healthcare Through AI

Rainbow hospital gives new lease of life to infant on ECMO support

The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease

Sun Pharma introduces treatment for plaque psoriasis in Canada

Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return

Apollo Hospitals announces free Covid-19 vaccines to kids with co-morbidities

The list of kids with co-morbidities eligible for vaccination would be announced by the government

Healthium Medtech introduces surgical wound dressing product

Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category

Ivenix selects Eastman Tritan copolyester for its new infusion system

Ivenix selected Tritan MXF for the pump exterior because of its excellent chemical resistance and durability in the face of the aggressive disinfection protocols needed to prevent the spread of healthcare-associated infections

Boehringer Ingelheim and partners to develop gene therapy for patients with cystic fibrosis

It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology

FDA approves Cyltezo, the first interchangeable biosimilar to Humira

Second interchangeable biosimilar product approved by agency